iShares Biotechnology ETF $IBB Shares Purchased by Concurrent Investment Advisors LLC

Concurrent Investment Advisors LLC lifted its position in iShares Biotechnology ETF (NASDAQ:IBB) by 809.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 35,689 shares of the financial services provider’s stock after acquiring an additional 31,766 shares during the period. Concurrent Investment Advisors LLC owned 0.07% of iShares Biotechnology ETF worth $6,023,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Darwin Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the second quarter worth approximately $25,000. Ashton Thomas Securities LLC acquired a new stake in shares of iShares Biotechnology ETF in the third quarter worth approximately $36,000. Parkside Financial Bank & Trust boosted its stake in shares of iShares Biotechnology ETF by 48.6% in the third quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock worth $38,000 after acquiring an additional 87 shares during the last quarter. Close Asset Management Ltd boosted its stake in shares of iShares Biotechnology ETF by 25.5% in the third quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock worth $50,000 after acquiring an additional 70 shares during the last quarter. Finally, Founders Financial Alliance LLC boosted its stake in shares of iShares Biotechnology ETF by 605.7% in the third quarter. Founders Financial Alliance LLC now owns 374 shares of the financial services provider’s stock worth $54,000 after acquiring an additional 321 shares during the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

NASDAQ IBB opened at $169.78 on Monday. The stock’s fifty day moving average is $170.35 and its two-hundred day moving average is $168.18. iShares Biotechnology ETF has a fifty-two week low of $116.25 and a fifty-two week high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were paid a dividend of $0.1218 per share. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a yield of 0.3%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.